Ironwood Pharmaceuticals (IRWD) Receivables - Other (2016 - 2020)
Ironwood Pharmaceuticals (IRWD) has disclosed Receivables - Other for 11 consecutive years, with $73.4 million as the latest value for Q1 2020.
- Quarterly Receivables - Other rose 5.88% to $73.4 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $73.4 million through Mar 2020, up 5.88% year-over-year, with the annual reading at $106.0 million for FY2019, 76.73% up from the prior year.
- Receivables - Other hit $73.4 million in Q1 2020 for Ironwood Pharmaceuticals, down from $106.0 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $106.0 million in Q4 2019 to a low of $50.0 million in Q1 2017.
- Historically, Receivables - Other has averaged $68.2 million across 5 years, with a median of $65.7 million in 2018.
- Biggest five-year swings in Receivables - Other: surged 99.62% in 2016 and later dropped 27.18% in 2018.
- Year by year, Receivables - Other stood at $63.9 million in 2016, then increased by 23.63% to $79.0 million in 2017, then dropped by 24.1% to $60.0 million in 2018, then skyrocketed by 76.73% to $106.0 million in 2019, then tumbled by 30.73% to $73.4 million in 2020.
- Business Quant data shows Receivables - Other for IRWD at $73.4 million in Q1 2020, $106.0 million in Q4 2019, and $94.4 million in Q3 2019.